Whether parents, children and schools alike can believe it or not - it is back to school season! At Epilepsy Ireland, we regularly support parents supporting children with the condition with the return to school, as well as schools themselves who may be seeking to learn more about a condition which affects over 10,000 children in Ireland.
A researcher from Trinity College Dublin is conducting a study examining how parents who care for a child with a chronic condition (such as epilepsy) manage the overlapping responsibilities of being a caregiver with other life roles, and how this affects their well-being.
The inquiry into Sodium Valproate has begun - find out how you can engage with the inquiry's work.
Researchers and research institutions - we have issued our 9th Research Funding Call!
As part of the continuing efforts to reduce the risks associated with the anti-seizure medication, Sodium Valproate (Epilim), the Health Products Regulatory Authority (HPRA) have recently reissued patient information materials and reminders to prescribers and pharmacists about their obligations under the Pregnancy Prevention Programme (PPP) and risk reduction measures associated with the medication.
We're delighted to see My Moving Brain project - ed by our colleagues in FutureNeuro - shortlisted for a prestigious award!
We have commenced the hiring process for the position of Communications Officer.
Working with our Advocacy & Communications Manager, this position will directly contribute to the advancement of our Strategic Plan, with a particular focus on the key aim of increasing the visibility of epilepsy and Epilepsy Ireland.
Can you help researchers from the University of Galway by sharing your experience?
Researchers from Maynooth University are inviting adults in Ireland with epilepsy to take part in a new study exploring the timing and storage of daily anti-seizure medication (ASMs). The study, called TimeAlign, is investigating whether the time of day and the regularity that people with epilepsy take their medication affects their seizure control.
We are looking forward to meeting with the Department of Health over the coming weeks to discuss one of our key advocacy campaigns.